Wednesday, October 15, 2014 4:05:39 PM
As to the timing of the process, the FDA staff have communicated that they are aware of the importance of this, that they are working on the drafting of the Final Rule, and stated that they hope to have it completed in a "timely fashion.". All meaning the timing is speculative. I believe their self-mandate is 180 days following the publishing of the Proposed Order in February and I think that was up around August 22nd, given that an FDA "Day" is defined as running business days, but excluding project hold days, requests for further info and data and the like and, to our knowledge, this baby has not been on hold. Wish I could say more fbs. To do so would be biased and misleading speculation, either for or against.
FEATURED Integrated Ventures Files Q3/2024 With Mining Revenues Of $1,983,250 And Positive Earnings Of $0.05 Cents Per Share • May 15, 2024 10:30 AM
Swifty Global Announces Impressive Financial Results for Q1 2024 • DRCR • May 15, 2024 10:25 AM
Branded Legacy Inc. Invites Shareholders to Celebrate Milestones at Open House: Announces Share Buyback and Commitment to Authorized Share Count • BLEG • May 15, 2024 8:30 AM
Alliance Creative Group (ACGX) Releases Q1 2024 Financial and Disclosure Report with an 88% increase in Net Income from Q1 2023 to Q1 2024 • ACGX • May 15, 2024 8:30 AM
Category V Biotech, Inc. Announces Letter of Intent to Acquire Genetic Networks, Expanding into Biotechnology Sector • CATV • May 15, 2024 8:00 AM
POET Announces Design Win and Collaboration with Foxconn Interconnect Technology for High-speed AI Systems • POET • May 14, 2024 10:09 AM